Activation of metabotropic glutamate receptors delays apoptosis of chick embryonic motor neurons in vitro

NeuroReport

Volumn 9, Issue 9, 1998, Pages 2039-2043

  Anneser, Johanna M H ^a   Horstmann, Sonja ^a   Weydt, Patrick ^a   Borasio, Gian Domenico ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Amyotrophic lateral sclerosis; Glutamate receptors; In situ hybridization; Motor neurons; Neuronal apoptosis; Signal transduction; Tissue culture

Indexed keywords

2 AMINO 4 PHOSPHONOBUTYRIC ACID; 3,5 DIHYDROXYPHENYLGLYCINE; GLUTAMATE RECEPTOR; GLUTAMATE RECEPTOR AGONIST; METABOTROPIC RECEPTOR;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL CELL; APOPTOSIS; ARTICLE; CONTROLLED STUDY; EMBRYO; IN SITU HYBRIDIZATION; MOTOR NEURON DISEASE; NERVE CELL NECROSIS; NEUROPATHOLOGY; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TISSUE CULTURE;

EID: 0032557929     PISSN: 09594965     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001756-199806220-00024     Document Type: Article

References (26)

1. Doble A. Therapie 50, 319-337 (1995).
2. Plaitakis A and Caroscio JT. Ann Neurol 22, 576-579 (1987).
3. Rothstein JD, Van Kammen M, Levey AI et al. Ann Neurol 38, 73-84 (1995).
4. Lacomblez L, Bensimon G, Leigh PN et al. Lancet 347, 1425-1431 (1996).
5. Pin, J-P and Duvoisin R. Neuropharmacology 34, 1-26 (1995).
6. Bruno A, Copani A, Battaglia G et al. Metabotropic glutamate receptors and neuronal degeneration in culture. In: Siesjö K and Wieloch T, eds. Advances in Neurology, 71: Cellular and Molecular Mechanisms of Ischemic Brain Damage. Philadelphia: Lippincott-Raven, 1996: 47-52.
7. Graham ME and Burgoyne RD. Eur J Pharmacol 288, 115-123 (1994).
8. Copani A, Bruno VM, Barresi V et al. J Neurochem 64, 101-108 (1995).
9. Henderson CE, Huchet M and Changeux JP. Nature 302, 609-611 (1983).
10. Bloch-Gallego M, Huchet M, El M'Hamdi H et al. Development 111, 221-232 (1991).
11. Weng G, Markus MA, Markus A et al. NeuroReport 7, 1077-1081 (1996).
12. Ito I, Kohda A, Tanabe S et al. NeuroReport 3, 1013-1016 (1992).
13. Ishida M; Saitoh T; Shimamoto K et al. Br J Pharmacol 109, 1169-1177 (1993).
14. Tones MA, Bendol N, Flor PJ et al NeuroReport 7, 117-120 (1995).
15. Doherty AJ, Palmer MJ, Henley JM et al. Neuropharmacology 36, 265-267 (1997).
16. Pellicciari R, Luneia R, Costantino G et al. J Med Chem 38, 3717-3719 (1995).
17. Toms NJ, Jane DE, Kemp MC et al. Br J Pharmacol, 119, 851-904 (1996).
18. Mu X, He J, Anderson DW et al. Ann Neurol 40, 379-386 (1996).
19. Burgoyne RD, Graham ME and Cambray-Deakin M. J Neurocytol 22, 689-695 (1993).
20. Borodezt K, Tsai P and D'Mello SR. Soc Neurosci Abstr 23, 2226 (1997).
21. Ciccarelli R, Sureda FX, Casabona G et al. Glia 21, 390-398 (1997).
22. Anneser JMH, Berthele A, Laurie DJ et al. Eur J Neurosci 7(Suppl. 8), 14.07 (1995).
23. Hanson MG and Barres BA. Soc Neurosci Abstr 23, 1158 (1997).
24. Pearson H, Graham M and Burgoyne RD. Neurosci Lett 142, 27-30 (1992).
25. Catania MV, Landwehrmeyer GB, Testa CM et al. Neuroscience 61, 481-495 (1994).
26. Alvarez FJ, Dewey DE, Carr PA et al. NeuroReport 8, 1711-1716 (1997).